Effects of genistein on the expression of hepatic genes in two rat strains (Sprague-Dawley and Wistar)

Toxicology Letters

Volumn 157, Issue 1, 2005, Pages 21-29

  Geis, Renate B ^a   Diel, Patrick ^b   Degen, Gisela H ^c   Vollmer, Günter ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

Author keywords

Estrogen; Gene expression; Genistein; Liver; Sprague Dawley rat; Wistar rat

Indexed keywords

APOLIPOPROTEIN A1; CALBINDIN; ETHINYLESTRADIOL; GENISTEIN; MESSENGER RNA; PHYTOESTROGEN; SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

RATTUS NORVEGICUS;

EID: 15744368039     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2005.01.001     Document Type: Article

References (33)

1. H. Adlercreutz Epidemiology of phytoestrogens Baillieres Clin. Endocrinol. Metab. 12 1998 605 623
2. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami Genistein, a specific inhibitor of tyrosine-specific protein kinases J. Biol. Chem. 262 1987 5592 5595
3. C.D. Allred, K.F. Allred, Y.H. Ju, L.M. Clausen, D.R. Doerge, S.L. Schantz, D.L. Korol, M.A. Wallig, and W.G. Helferich Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats Carcinogenesis 25 2004 211 218
4. D. Alvaro, G. Alpini, P. Onori, A. Franchitto, S. Glaser, G. Le Sage, F. Folli, A. Attili, and E. Gaudio Alfa and beta estrogen receptors and the biliary tree Mol. Cell. Endocrinol. 193 2002 105 108
5. B.S. An, S.K. Kang, J.H. Shin, and E.B. Jeung Stimulation of calbindin-D (9 kDa) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol Mol. Cell. Endocrinol. 191 2002 177 186
6. L.J. Black, M. Sato, E.R. Rowley, D.E. Magee, A. Bekele, D.C. Williams, G.J. Cullinan, R. Bendele, R.F. Kauffman, and W.R. Bensch Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats J. Clin. Invest. 93 1994 63 69
7. P. Diel, S. Olff, S. Schmidt, and H. Michna Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7 Planta. Med. 67 2001 510 514
8. P. Diel, S. Schmidt, and G. Vollmer In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 777 2002 191 202
9. P. Diel, S. Schmidt, G. Vollmer, P. Janning, A. Upmeier, H. Michna, H.M. Bolt, and G.H. Degen Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens Arch. Toxicol. 78 2004 183 193
10. P. Diel, A. Walter, K.H. Fritzemeier, C. Hegele-Hartung, and R. Knauthe Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus J. Steroid. Biochem. Mol. Biol. 55 1995 363 373
11. C. Evans, M. Bouzyk, S. Cox, D. Warne, S.P. Bryant, and N.K. Spurr Chromosomal assignment of 79 cDNAs from a range of human tissues Genomics 31 1996 130 134
12. M.J. Evans, K. Lai, L.J. Shaw, D.C. Harnish, and C.C. Chadwick Estrogen receptor alpha inhibits IL-1beta induction of gene expression in the mouse liver Endocrinology 143 2002 2559 25570
13. A.C. Hopert, A. Beyer, K. Frank, E. Strunck, W. Wünsche, and G. Vollmer Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model Env. Health Persp. 106 1998 581 586
14. F.Y. Jin, V.S. Kamanna, and M.L. Kashyap Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells Arterioscler. Thromb. Vasc. Biol. 18 1998 999 1006
15. L.A. Jones, and R.A. Hajek Effects of estrogenic chemicals on development Environ. Health Perspect. 103 Suppl. 7 1995 63 67
16. T. Kalme, M. Loukovaara, R. Koistinen, H. Koistinen, M. Angervo, P. Leinonen, and M. Seppala Estradiol increases the production of sex hormone-binding globulin but not insulin-like growth factor binding protein-1 in cultured human hepatoma cells Fertil. Steril. 72 1999 325 329
17. J. Krisinger, M. Strom, H.D. Darwish, K. Perlman, C. Smith, and H.F. DeLuca Induction of calbindin-D 9 kDa mRNA but not calcium transport in rat intestine by 1,25-dihydroxy Vitamin D3 24-homologs J. Biol. Chem. 266 1991 1910 1913
18. G. Kuiper, and J. Gustafsson The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens FEBS Lett. 410 1997 87 90
19. S.J. Kwack, O. Kwon, H.S. Kim, S.S. Kim, S.H. Kim, K.H. Sohn, R.D. Lee, C.H. Park, E.B. Jeung, B.S. An, and K.L. Park Comparative evaluation of alkylphenolic compounds on estrogenic activity in vitro and in vivo J. Toxicol. Environ. Health A 65 2002 419 431
20. S. Lamon-Fava Genistein activates apolipoprotein A-I gene expression in the human hepatoma cell line Hep G2 J. Nutr. 130 2000 2489 2492
21. F. L'Horset, C. Blin, S. Colnot, M. Lambert, M. Thomasset, and C. Perret Calbindin-D9 kDa gene expression in the uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element Endocrinology 134 1994 11 18
22. M.F. McCarty Up-regulation of IGF-binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity Med. Hypotheses 48 1997 297 308
23. R.J. Miksicek Estrogenic flavonoids: structural requirements for biological activity Proc. Soc. Exp. Biol. Med. 208 1995 44 50
24. P. Molnar, and L.J. Murphy Effects of oestrogen on rat uterine expression of insulin-like growth factor-binding proteins J. Mol. Endocrinol. 13 1994 59 67
25. R.R. Newbold, E.P. Banks, B. Bullock, and W.N. Jefferson Uterine adenocarcinoma in mice treated neonatally with genistein Cancer. Res. 61 2001 4325 4328
26. J.W. Owens, and J. Ashby Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development Crit. Rev. Toxicol. 32 2002 445 520
27. C. Perret, F. L'Horset, and M. Thomasset DNase I-hypersensitive sites are associated, in a tissue-specific manner, with expression of the calbindin-D9 kDa-encoding gene Gene 108 1991 227 235
28. E.J. Schaefer, D.M. Foster, L.A. Zech, F.T. Lindgren, H.B. Brewer Jr., and R.I. Levy The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females J. Clin. Endocrinol. Metab. 57 1983 262 267
29. D.A. Shutt, and R.I. Cox Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro J. Endocrinol. 52 1972 299 310
30. Y.T. van der Schouw, M.J. de Kleijn, P.H. Peeters, and D.E. Grobbee Phyto-oestrogens and cardiovascular disease risk Nutr. Metab. Cardiovasc. Dis. 10 2000 154 167
31. B.W. Walsh, H. Li, and F.M. Sacks Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism J. Lipid. Res. 35 1994 2083 2093
32. P.L. Whitten, and H.B. Patisaul Cross-species and interassay comparisons of phytoestrogen action Environ. Health Perspect. 109 Suppl. 1 2001 5 20
33. J. Winer, K.C. Jung, I. Shackel, and P.M. Williams Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro Anal. Biochem. 270 1999 41 49